Skip to main content
British Medical Journal logoLink to British Medical Journal
. 1978 Jul 1;2(6129):10–11. doi: 10.1136/bmj.2.6129.10

Treatment of oat cell carcinoma of the lung: complete remissions, acceptable complications, and improved survival.

F A Greco, R L Richardson, S F Schulman, S Stroup, R K Oldham
PMCID: PMC1605667  PMID: 209843

Abstract

Oat cell lung cancer is a common disease which is usually disseminated by the time it is diagnosed. Treatment with cyclic combination chemotherapy (cyclophosphamide, doxorubicin, vincristine) administered concurrently with radiotherapy to the chest lesion and subsequent prophylactic brain irradiation was investigated in 36 patients with oat-cell carcinoma of the lung. Complete remissions occurred in 26 of the patients (15 of the 16 with limited-stage disease and 11 of the 20 with extensive-stage disease). Symptomatic improvement occurred in all patients. Twelve of the 16 patients with limited disease remained well and free of disease for over a year. The results were equivalent to those of a similar though more intensive regimen, but the toxicity was much less (there were no treatment-related deaths). Transient granulocytopenia with the risk of infection was the most serious complication. Survival and quality of life have been improved for all patients, particularly those with limited disease, who have previously responded poorly to treatment.

Full text

PDF

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bunn P. A., Jr, Cohen M. H., Ihde D. C., Fossieck B. E., Jr, Matthews M. J., Minna J. D. Advances in small cell bronchogenic carcinoma. Cancer Treat Rep. 1977 May-Jun;61(3):333–342. [PubMed] [Google Scholar]
  2. Greco F. A., Brereton H. D., Kent H., Zimbler H., Merrill J., Johnson R. E. Adriamycin and enhanced radiation reaction in normal esophagus and skin. Ann Intern Med. 1976 Sep;85(3):294–298. doi: 10.7326/0003-4819-85-3-294. [DOI] [PubMed] [Google Scholar]
  3. Johnson R. E., Brereton H. D., Kent C. H. Small-cell carcinoma of the lung: attempt to remedy causes of past therapeutic failure. Lancet. 1976 Aug 7;2(7980):289–291. doi: 10.1016/s0140-6736(76)90736-4. [DOI] [PubMed] [Google Scholar]
  4. Kent C. H., Brereton H. D., Johnson R. E. "Total" therapy for oat cell carcinoma of the lung. Int J Radiat Oncol Biol Phys. 1977 May-Jun;2(5-6):427–432. doi: 10.1016/0360-3016(77)90153-5. [DOI] [PubMed] [Google Scholar]
  5. Mountain C. F., Carr D. T., Anderson W. A. A system for the clinical staging of lung cancer. Am J Roentgenol Radium Ther Nucl Med. 1974 Jan;120(1):130–138. doi: 10.2214/ajr.120.1.130. [DOI] [PubMed] [Google Scholar]

Articles from British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES